Report cover image

Global Scopolamine Transdermal Patch Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 183 Pages
SKU # APRC20355900

Description

Summary

According to APO Research, The global Scopolamine Transdermal Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Scopolamine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Scopolamine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Scopolamine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Scopolamine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Scopolamine Transdermal Patch include Novartis, Mylan, GSK, BengbuBBCATushan Pharmaceutical Co, Perrigo and Baxter, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Scopolamine Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Scopolamine Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Scopolamine Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Scopolamine Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Scopolamine Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Scopolamine Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.

Scopolamine Transdermal Patch Segment by Company

Novartis
Mylan
GSK
BengbuBBCATushan Pharmaceutical Co
Perrigo
Baxter
Scopolamine Transdermal Patch Segment by Type

1mg
1.5mg
Scopolamine Transdermal Patch Segment by Application

Nausea/Vomiting
Parkinsonian Tremor
Motion Sickness
Others
Scopolamine Transdermal Patch Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Scopolamine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Scopolamine Transdermal Patch market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Scopolamine Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Scopolamine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Scopolamine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

183 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Scopolamine Transdermal Patch Market Size, 2020 VS 2024 VS 2031
1.3 Global Scopolamine Transdermal Patch Market Size Estimates and Forecasts (2020-2031)
1.4 Global Scopolamine Transdermal Patch Sales Estimates and Forecasts (2020-2031)
1.5 Global Scopolamine Transdermal Patch Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Scopolamine Transdermal Patch Market Dynamics
2.1 Scopolamine Transdermal Patch Industry Trends
2.2 Scopolamine Transdermal Patch Industry Drivers
2.3 Scopolamine Transdermal Patch Industry Opportunities and Challenges
2.4 Scopolamine Transdermal Patch Industry Restraints
3 Scopolamine Transdermal Patch Market by Manufacturers
3.1 Global Scopolamine Transdermal Patch Revenue by Manufacturers (2020-2025)
3.2 Global Scopolamine Transdermal Patch Sales by Manufacturers (2020-2025)
3.3 Global Scopolamine Transdermal Patch Average Sales Price by Manufacturers (2020-2025)
3.4 Global Scopolamine Transdermal Patch Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Scopolamine Transdermal Patch Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Scopolamine Transdermal Patch Manufacturers, Product Type & Application
3.7 Global Scopolamine Transdermal Patch Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Scopolamine Transdermal Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Scopolamine Transdermal Patch Players Market Share by Revenue in 2024
3.8.3 2024 Scopolamine Transdermal Patch Tier 1, Tier 2, and Tier 3
4 Scopolamine Transdermal Patch Market by Type
4.1 Scopolamine Transdermal Patch Type Introduction
4.1.1 1mg
4.1.2 1.5mg
4.2 Global Scopolamine Transdermal Patch Sales by Type
4.2.1 Global Scopolamine Transdermal Patch Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Scopolamine Transdermal Patch Sales by Type (2020-2031)
4.2.3 Global Scopolamine Transdermal Patch Sales Market Share by Type (2020-2031)
4.3 Global Scopolamine Transdermal Patch Revenue by Type
4.3.1 Global Scopolamine Transdermal Patch Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Scopolamine Transdermal Patch Revenue by Type (2020-2031)
4.3.3 Global Scopolamine Transdermal Patch Revenue Market Share by Type (2020-2031)
5 Scopolamine Transdermal Patch Market by Application
5.1 Scopolamine Transdermal Patch Application Introduction
5.1.1 Nausea/Vomiting
5.1.2 Parkinsonian Tremor
5.1.3 Motion Sickness
5.1.4 Others
5.2 Global Scopolamine Transdermal Patch Sales by Application
5.2.1 Global Scopolamine Transdermal Patch Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Scopolamine Transdermal Patch Sales by Application (2020-2031)
5.2.3 Global Scopolamine Transdermal Patch Sales Market Share by Application (2020-2031)
5.3 Global Scopolamine Transdermal Patch Revenue by Application
5.3.1 Global Scopolamine Transdermal Patch Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Scopolamine Transdermal Patch Revenue by Application (2020-2031)
5.3.3 Global Scopolamine Transdermal Patch Revenue Market Share by Application (2020-2031)
6 Global Scopolamine Transdermal Patch Sales by Region
6.1 Global Scopolamine Transdermal Patch Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Scopolamine Transdermal Patch Sales by Region (2020-2031)
6.2.1 Global Scopolamine Transdermal Patch Sales by Region (2020-2025)
6.2.2 Global Scopolamine Transdermal Patch Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Scopolamine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Scopolamine Transdermal Patch Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Scopolamine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Scopolamine Transdermal Patch Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Scopolamine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Scopolamine Transdermal Patch Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Scopolamine Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Scopolamine Transdermal Patch Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Scopolamine Transdermal Patch Revenue by Region
7.1 Global Scopolamine Transdermal Patch Revenue by Region
7.1.1 Global Scopolamine Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Scopolamine Transdermal Patch Revenue by Region (2020-2025)
7.1.3 Global Scopolamine Transdermal Patch Revenue by Region (2026-2031)
7.1.4 Global Scopolamine Transdermal Patch Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Scopolamine Transdermal Patch Revenue (2020-2031)
7.2.2 North America Scopolamine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Scopolamine Transdermal Patch Revenue (2020-2031)
7.3.2 Europe Scopolamine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Scopolamine Transdermal Patch Revenue (2020-2031)
7.4.2 Asia-Pacific Scopolamine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Scopolamine Transdermal Patch Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Scopolamine Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Novartis
8.1.1 Novartis Comapny Information
8.1.2 Novartis Business Overview
8.1.3 Novartis Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Novartis Scopolamine Transdermal Patch Product Portfolio
8.1.5 Novartis Recent Developments
8.2 Mylan
8.2.1 Mylan Comapny Information
8.2.2 Mylan Business Overview
8.2.3 Mylan Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Mylan Scopolamine Transdermal Patch Product Portfolio
8.2.5 Mylan Recent Developments
8.3 GSK
8.3.1 GSK Comapny Information
8.3.2 GSK Business Overview
8.3.3 GSK Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 GSK Scopolamine Transdermal Patch Product Portfolio
8.3.5 GSK Recent Developments
8.4 BengbuBBCATushan Pharmaceutical Co
8.4.1 BengbuBBCATushan Pharmaceutical Co Comapny Information
8.4.2 BengbuBBCATushan Pharmaceutical Co Business Overview
8.4.3 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Portfolio
8.4.5 BengbuBBCATushan Pharmaceutical Co Recent Developments
8.5 Perrigo
8.5.1 Perrigo Comapny Information
8.5.2 Perrigo Business Overview
8.5.3 Perrigo Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Perrigo Scopolamine Transdermal Patch Product Portfolio
8.5.5 Perrigo Recent Developments
8.6 Baxter
8.6.1 Baxter Comapny Information
8.6.2 Baxter Business Overview
8.6.3 Baxter Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Baxter Scopolamine Transdermal Patch Product Portfolio
8.6.5 Baxter Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Scopolamine Transdermal Patch Value Chain Analysis
9.1.1 Scopolamine Transdermal Patch Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Scopolamine Transdermal Patch Production Mode & Process
9.2 Scopolamine Transdermal Patch Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Scopolamine Transdermal Patch Distributors
9.2.3 Scopolamine Transdermal Patch Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.